Humacyte, Inc. (HUMA) Q1 2026 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Humacyte, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:04.017 Good morning, ladies and gentlemen, and welcome to the Humacyte First Quarter 2026 Earnings 00:00:04.017 -- 00:00:08.264 Conference Call. Currently, all participants are in listen-only mode. 00:00:08.264 -- 00:00:11.629 Later, we'll conduct a question-and-answer session, and instructions will follow at that 00:00:11.629 -- 00:00:13.051 time. 00:00:13.051 -- 00:00:16.236 As a reminder, this conference call is being recorded. 00:00:16.236 -- 00:00:19.522 I'll now turn the call over to Tom Johnson with LifeSite Advisors. 00:00:19.522 -- 00:00:21.922 Please go ahead, Tom. 00:00:22.226 -- 00:00:25.749 Thank you, Operator. Before we proceed with the call, I would like to remind everyone 00:00:25.749 -- 00:00:29.574 that certain statements made during this call are forward-looking statements under U.S. 00:00:29.574 -- 00:00:33.701 federal securities laws. These statements are subject to risks and uncertainties that 00:00:33.701 -- 00:00:38.508 could cause actual results to differ materially from historical experience or present 00:00:38.508 -- 00:00:39.970 expectations. 00:00:39.970 -- 00:00:43.776 Additional information concerning factors that could cause actual results to differ from 00:00:43.776 -- 00:00:48.462 statements made on this call is contained in our periodic reports filed with the SEC. 00:00:48.462 -- 00:00:52.286 The forward-looking statements made during this call speak only as the date hereof, and 00:00:52.286 -- 00:00:56.791 the company undertakes no obligation to update or revise forward-looking statements accepted 00:00:56.791 -- 00:01:01.196 as required by law. Information presented on this call is contained in the press release 00:01:01.196 -- 00:01:05.221 we issued this morning and in our Form 10-Q, which after filin...